“…However, the application of some small molecule carriers frequently used for ion interference therapy, often encounters obstacles, such as short internal circulation, dose-dependent toxicity, poor specific recognition ability and a low dose of ion release, which limits the effect of cancer treatment [ 7 ]. Based on this, inorganic nanoparticles such as Ca 2 O, ZnO, CaCO 3 , BPS (black phosphorus) and NaCl have been constructed for ion interference treatment, with the advantages of long internal circulation, efficient inhibition of tumor development, high biocompatibility and strong specific recognition ability (Table 1) [ 4 , 8 , 9 , 10 , 11 ]. Because of these advantages, ion interference therapy based on inorganic nanoparticles, as an emerging cancer treatment, represents strong competition for traditional cancer treatment.…”